Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/05
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 12/31/07
End: 06/30/23
Due: 06/30/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Efficacy of T Cell Genetic Immunotherapy for HIV | NCT00131560 | VIRxSYS Corporation | user2@example.com | None | 2005-07-31 | 2023-06-30 | 2024-06-30 | - | - | 2025-07-14 |
| A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial | NCT00622232 | VIRxSYS Corporation | user2@example.com | None | 2007-12-31 | 2023-06-30 | 2024-06-30 | - | - | 2025-07-14 |